IL Pharmaceuticals

Teva Pharmaceutical Industries Limited (TEVA)

Track

Track

Teva Pharmaceutical Industries experienced significant insider selling over the past ninety days, totaling approximately 19.7 million dollars. Twelve transactions occurred, primarily involving planned or proposed divestments by executives and major shareholders. These activities follow a period where the stock price appreciated by 27.5 percent, occurring shortly after the company's most recent July results.
Ticker: TEVA Exchange: TLV
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
405.44
Quantity 47,345 +20.9%
Value US$964,110
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
223.00
Quantity 92,745 -25.1%
Value US$4,940,564
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
198.75
Quantity 64,167 +44.7%
Value US$1,647,257
MIGNONE ROBERTO Non-Executive Director
Transaction date
Sale
Price
39.06
Quantity 1,000 -100.0%
Value US$100,000
Savage Brian Officer; CHIEF LEGAL OFFICER Officer
Transaction date
Proposed sale
Price
38.85
Quantity 1,000
Value US$100,000
Weiss Amir Chief Accounting Officer Officer
Transaction date
Sale
Price
37.63
Quantity 2,500 -16.1%
Value US$94,077
Weiss Amir Chief Accounting Officer Officer
Transaction date
Sale
Price
37.61
Quantity 6,945 -34.7%
Value US$261,224
Satchi-Fainaro Ronit Non-Executive Director
Transaction date
Sale
Price
37.25
Quantity 415 -0.4%
Value US$15,459
Lippman Evan EVP, Business Development Officer
Transaction date
Planned sale
Price
36.57
Quantity 18,600 -42.1%
Value US$680,291
Lippman Evan Officer; EVP BUSINESS DEVELOPMENT Officer
Transaction date
Proposed sale
Price
36.57
Quantity 18,600
Value US$680,291
Zaks Tal Zvi Non-Executive Director
Transaction date
Sale
Price
34.87
Quantity 17 -0.0%
Value US$593
Jover Placid See "Remarks" Officer
Transaction date
Planned sale
Price
34.88
Quantity 12,827 -65.4%
Value US$447,351
Hughes Eric A See "Remarks" Officer
Transaction date
Planned sale
Price
34.88
Quantity 25,578 -15.9%
Value US$892,051
Jover Placid Executive VP, Chief HR Officer Officer
Transaction date
Proposed sale
Price
34.88
Quantity 12,827
Value US$447,351
Hughes Eric A Executive VP Global R&D and Chief Med Officer Officer
Transaction date
Proposed sale
Price
34.88
Quantity 25,578
Value US$892,051
Hughes Eric A Executive VP Global R&D and Chief Med Officer Officer
Transaction date
Proposed sale
Price
34.88
Quantity 25,578
Value US$892,051
Shields Matthew EVP, Global Operations Officer
Transaction date
Sale
Price
32.19
Quantity 9,989 -100.0%
Value US$321,547
Shields Matthew EVP, Global Operations Officer
Transaction date
Sale
Price
32.19
Quantity 9,989 -100.0%
Value US$321,547
Shields Matthew Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS Officer
Transaction date
Proposed sale
Price
32.19
Quantity 9,989
Value US$321,547
Kalif Eliyahu Sharon EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
34.10
Quantity 106,563 -61.9%
Value US$3,633,308
Kalif Eliyahu Sharon Officer; EVP CHIEF FINANCIAL OFFICER Officer
Transaction date
Proposed sale
Price
34.10
Quantity 106,563
Value US$3,633,305
Kalif Eliyahu Sharon Officer; EVP CHIEF FINANCIAL OFFICER Officer
Transaction date
Proposed sale
Price
34.10
Quantity 106,563
Value US$3,633,305
Francis Richard D President and CEO Officer
Transaction date
Planned sale
Price
34.35
Quantity 6,153 -0.5%
Value US$211,356
Francis Richard D Officer; PRESIDENT AND CEO Officer
Transaction date
Proposed sale
Price
34.35
Quantity 6,153
Value US$211,356
Shields Matthew EVP, Global Operations Officer
Transaction date
Planned sale
Price
32.87
Quantity 16,195 -61.9%
Value US$532,330
Shields Matthew Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS Officer
Transaction date
Proposed sale
Price
32.87
Quantity 16,195
Value US$532,330
Lippman Evan EVP, Business Development Officer
Transaction date
Planned sale
Price
35.58
Quantity 35,912 -44.8%
Value US$1,277,900
Lippman Evan EVP, Business Development Officer
Transaction date
Planned sale
Price
35.58
Quantity 35,912 -44.8%
Value US$1,277,900
Lippman Evan EVP, Business Development Officer
Transaction date
Planned sale
Price
35.58
Quantity 5,746 -48.5%
Value US$204,467
Lippman Evan EVP, Business Development Officer
Transaction date
Planned sale
Price
35.58
Quantity 5,746 -48.5%
Value US$204,467
Kalif Eliyahu Sharon EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.61
Quantity 153,251 -47.1%
Value US$5,457,375
Lippman Evan Officer; EXECUTIVE VP BUSINESS DEVELOPMENT Officer
Transaction date
Proposed sale
Price
35.58
Quantity 41,658
Value US$1,482,367
Kalif Eliyahu Sharon Officer; EVP CHIEF FINANCIAL OFFICER Officer
Transaction date
Proposed sale
Price
35.61
Quantity 153,251
Value US$5,457,369
Weiss Amir Chief Accounting Officer Officer
Transaction date
Sale
Price
36.00
Quantity 10,679 -34.8%
Value US$384,444
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Sale
Price
35.40
Quantity 30,000 -35.0%
Value US$1,062,000
Daniell Richard Officer; EXECUTIVE VP EUROPEAN COMMERCIAL Officer
Transaction date
Proposed sale
Price
35.40
Quantity 30,000
Value US$1,062,000
Sabag Mark See "Remarks" Officer
Transaction date
Sale
Price
34.99
Quantity 144,180 -64.1%
Value US$5,045,118
Sabag Mark Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL Officer
Transaction date
Proposed sale
Price
34.99
Quantity 144,180
Value US$5,045,123
Fox Christine EVP, U.S. Commercial Officer
Transaction date
Sale
Price
35.31
Quantity 21,258 -25.0%
Value US$750,620
Christine Fox Officer Officer
Transaction date
Proposed sale
Price
35.31
Quantity 21,258
Value US$750,633
Sabag Mark See "Remarks" Officer
Transaction date
Sale
Price
30.14
Quantity 62,102 -21.6%
Value US$1,871,816
Sabag Mark Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL Officer
Transaction date
Proposed sale
Price
30.14
Quantity 62,102
Value US$1,871,815
Francis Richard D President and CEO Officer
Transaction date
Planned sale
Price
31.67
Quantity 20,025 -1.7%
Value US$634,160
Fox Christine EVP, U.S. Commercial Officer
Transaction date
Planned sale
Price
31.67
Quantity 7,924 -8.5%
Value US$250,940
Hughes Eric A See "Remarks" Officer
Transaction date
Planned sale
Price
31.67
Quantity 9,533 -8.1%
Value US$301,895
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Planned sale
Price
31.67
Quantity 17,295 -16.8%
Value US$547,705
Jover Placid See "Remarks" Officer
Transaction date
Planned sale
Price
31.67
Quantity 14,150 -67.6%
Value US$448,108
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
31.67
Quantity 1,127 -9.4%
Value US$35,690
Shields Matthew EVP, Global Operations Officer
Transaction date
Planned sale
Price
31.67
Quantity 17,295 -63.4%
Value US$547,705
Shields Matthew Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS Officer
Transaction date
Proposed sale
Price
31.67
Quantity 17,295
Value US$547,705
Jover Placid Officer; EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER Officer
Transaction date
Proposed sale
Price
31.67
Quantity 14,150
Value US$448,108
Savage Brian Officer; INTERIM CHIEF LEGAL OFFICER Officer
Transaction date
Proposed sale
Price
31.67
Quantity 1,127
Value US$35,690
Fox Christine Officer; EVP HEAD OF US COMMERCIAL Officer
Transaction date
Proposed sale
Price
31.67
Quantity 7,924
Value US$250,940
Francis Richard D Officer; PRESIDENT AND CEO Officer
Transaction date
Proposed sale
Price
31.67
Quantity 20,025
Value US$634,160
Hughes Eric A Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER Officer
Transaction date
Proposed sale
Price
31.67
Quantity 9,533
Value US$301,895
Daniell Richard Officer; EXECUTIVE VP EUROPEAN COMMERCIAL Officer
Transaction date
Proposed sale
Price
31.67
Quantity 17,295
Value US$547,705
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Planned sale
Price
32.95
Quantity 37,372 -30.4%
Value US$1,231,310
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Planned sale
Price
32.46
Quantity 20,461 -14.2%
Value US$664,256
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Planned sale
Price
32.46
Quantity 33,512 -21.4%
Value US$1,087,950
Francis Richard D President and CEO Officer
Transaction date
Planned sale
Price
32.46
Quantity 23,393 -2.0%
Value US$759,442
Hughes Eric A See "Remarks" Officer
Transaction date
Planned sale
Price
32.46
Quantity 11,277 -10.4%
Value US$366,102
Fox Christine EVP, U.S. Commercial Officer
Transaction date
Planned sale
Price
32.46
Quantity 9,098 -10.8%
Value US$295,362
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
32.46
Quantity 1,186 -12.3%
Value US$38,503
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
32.46
Quantity 1,489 -19.4%
Value US$48,340
Fox Christine Officer; EVP HEAD OF US COMMERCIAL Officer
Transaction date
Proposed sale
Price
32.46
Quantity 9,908
Value US$321,658
Francis Richard D Officer; PRESIDENT AND CEO Officer
Transaction date
Proposed sale
Price
32.46
Quantity 23,393
Value US$759,442
Hughes Eric A Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER Officer
Transaction date
Proposed sale
Price
32.46
Quantity 11,277
Value US$366,102
Daniell Richard Officer; EXECUTIVE VP EUROPEAN COMMERCIAL Officer
Transaction date
Proposed sale
Price
32.66
Quantity 91,345
Value US$2,983,516
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Planned sale
Price
32.36
Quantity 66,735 -35.1%
Value US$2,159,538
Daniell Richard EVP, Europe Commercial Officer
Transaction date
Planned sale
Price
32.36
Quantity 62,250 -56.3%
Value US$2,014,404
Savage Brian Interim Chief Legal Officer Officer
Transaction date
Sale
Price
32.36
Quantity 1,274 -30.3%
Value US$41,227
Francis Richard D President and CEO Officer
Transaction date
Planned sale
Price
32.36
Quantity 412,032 -26.9%
Value US$13,333,314
Francis Richard D President and CEO Officer
Transaction date
Planned sale
Price
32.36
Quantity 30,903 -4.6%
Value US$1,000,018
Hughes Eric A See "Remarks" Officer
Transaction date
Planned sale
Price
32.36
Quantity 68,685 -44.5%
Value US$2,222,640
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-22 2026-09-18 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
47,345 +20.9%
405.44
US$964,110 		47,345 +20.9% 405.44 US$964,110
2026-09-22 2026-09-18 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
92,745 -25.1%
223.00
US$4,940,564 		92,745 -25.1% 223.00 US$4,940,564
2026-09-22 2026-09-18 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
64,167 +44.7%
198.75
US$1,647,257 		64,167 +44.7% 198.75 US$1,647,257
2026-09-22 2026-09-18 S Sale
MIGNONE ROBERTO
Non-Executive Director
1,000 -100.0%
39.06
US$100,000 		1,000 -100.0% 39.06 US$100,000
2026-09-21 2026-09-18 PrS Proposed sale
Savage Brian

Officer; CHIEF LEGAL OFFICER

Officer
1,000
38.85
US$100,000 		1,000 38.85 US$100,000
2026-09-18 2026-09-18 PrS Proposed sale
Bridger Management, LLC (1)

Shareholder
1,000
39.19
US$100,000 		1,000 39.19 US$100,000
2026-08-25 2026-08-21 S Sale
Weiss Amir

Chief Accounting Officer

Officer
2,500 -16.1%
37.63
US$94,077 		2,500 -16.1% 37.63 US$94,077
2026-08-25 2026-08-21 S Sale
Weiss Amir

Chief Accounting Officer

Officer
6,945 -34.7%
37.61
US$261,224 		6,945 -34.7% 37.61 US$261,224
2026-08-25 2026-08-21 S Sale
Satchi-Fainaro Ronit
Non-Executive Director
415 -0.4%
37.25
US$15,459 		415 -0.4% 37.25 US$15,459
2026-08-19 2026-08-17 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
18,600 -42.1%
36.57
US$680,291 		18,600 -42.1% 36.57 US$680,291
2026-08-17 2026-08-17 PrS Proposed sale
Lippman Evan

Officer; EVP BUSINESS DEVELOPMENT

Officer
18,600
36.57
US$680,291 		18,600 36.57 US$680,291
2026-08-10 2026-08-05 S Sale
Zaks Tal Zvi
Non-Executive Director
17 -0.0%
34.87
US$593 		17 -0.0% 34.87 US$593
2026-08-05 2026-08-03 PlS Planned sale
Jover Placid

See "Remarks"

Officer
12,827 -65.4%
34.88
US$447,351 		12,827 -65.4% 34.88 US$447,351
2026-08-05 2026-08-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
25,578 -15.9%
34.88
US$892,051 		25,578 -15.9% 34.88 US$892,051
2026-08-03 2026-08-03 PrS Proposed sale
Jover Placid

Executive VP, Chief HR Officer

Officer
12,827
34.88
US$447,351 		12,827 34.88 US$447,351
2026-08-03 2026-08-03 PrS Proposed sale
Hughes Eric A

Executive VP Global R&D and Chief Med Officer

Officer
25,578
34.88
US$892,051 		25,578 34.88 US$892,051
2026-08-03 2026-08-03 PrS Proposed sale
Hughes Eric A

Executive VP Global R&D and Chief Med Officer

Officer
25,578
34.88
US$892,051 		25,578 34.88 US$892,051
2026-06-22 2026-06-18 S Sale
Shields Matthew

EVP, Global Operations

Officer
9,989 -100.0%
32.19
US$321,547 		9,989 -100.0% 32.19 US$321,547
2026-06-22 2026-06-18 S Sale
Shields Matthew

EVP, Global Operations

Officer
9,989 -100.0%
32.19
US$321,547 		9,989 -100.0% 32.19 US$321,547
2026-06-18 2026-06-18 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
9,989
32.19
US$321,547 		9,989 32.19 US$321,547
2026-06-16 2026-06-11 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
106,563 -61.9%
34.10
US$3,633,308 		106,563 -61.9% 34.10 US$3,633,308
2026-06-11 2026-06-11 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
106,563
34.10
US$3,633,305 		106,563 34.10 US$3,633,305
2026-06-11 2026-06-11 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
106,563
34.10
US$3,633,305 		106,563 34.10 US$3,633,305
2026-06-08 2026-06-05 PlS Planned sale
Francis Richard D

President and CEO

Officer
6,153 -0.5%
34.35
US$211,356 		6,153 -0.5% 34.35 US$211,356
2026-06-05 2026-06-05 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
6,153
34.35
US$211,356 		6,153 34.35 US$211,356
2026-06-04 2026-06-03 PlS Planned sale
Shields Matthew

EVP, Global Operations

Officer
16,195 -61.9%
32.87
US$532,330 		16,195 -61.9% 32.87 US$532,330
2026-06-03 2026-06-03 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
16,195
32.87
US$532,330 		16,195 32.87 US$532,330
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
153,251 -47.1%
35.61
US$5,457,375 		153,251 -47.1% 35.61 US$5,457,375
2026-05-14 2026-05-14 PrS Proposed sale
Lippman Evan

Officer; EXECUTIVE VP BUSINESS DEVELOPMENT

Officer
41,658
35.58
US$1,482,367 		41,658 35.58 US$1,482,367
2026-05-14 2026-05-14 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
153,251
35.61
US$5,457,369 		153,251 35.61 US$5,457,369
2026-05-07 2026-05-06 S Sale
Weiss Amir

Chief Accounting Officer

Officer
10,679 -34.8%
36.00
US$384,444 		10,679 -34.8% 36.00 US$384,444
2026-05-07 2026-05-05 S Sale
Daniell Richard

EVP, Europe Commercial

Officer
30,000 -35.0%
35.40
US$1,062,000 		30,000 -35.0% 35.40 US$1,062,000
2026-05-05 2026-05-05 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
30,000
35.40
US$1,062,000 		30,000 35.40 US$1,062,000
2026-05-04 2026-05-01 S Sale
Sabag Mark

See "Remarks"

Officer
144,180 -64.1%
34.99
US$5,045,118 		144,180 -64.1% 34.99 US$5,045,118
2026-05-04 2026-05-01 PrS Proposed sale
Sabag Mark

Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL

Officer
144,180
34.99
US$5,045,123 		144,180 34.99 US$5,045,123
2026-05-04 2026-04-30 S Sale
Fox Christine

EVP, U.S. Commercial

Officer
21,258 -25.0%
35.31
US$750,620 		21,258 -25.0% 35.31 US$750,620
2026-04-30 2026-04-30 PrS Proposed sale
Christine Fox

Officer

Officer
21,258
35.31
US$750,633 		21,258 35.31 US$750,633
2026-03-19 2026-03-17 S Sale
Sabag Mark

See "Remarks"

Officer
62,102 -21.6%
30.14
US$1,871,816 		62,102 -21.6% 30.14 US$1,871,816
2026-03-17 2026-03-17 PrS Proposed sale
Sabag Mark

Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL

Officer
62,102
30.14
US$1,871,815 		62,102 30.14 US$1,871,815
2026-03-09 2026-03-05 PlS Planned sale
Francis Richard D

President and CEO

Officer
20,025 -1.7%
31.67
US$634,160 		20,025 -1.7% 31.67 US$634,160
2026-03-09 2026-03-05 PlS Planned sale
Fox Christine

EVP, U.S. Commercial

Officer
7,924 -8.5%
31.67
US$250,940 		7,924 -8.5% 31.67 US$250,940
2026-03-09 2026-03-05 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
9,533 -8.1%
31.67
US$301,895 		9,533 -8.1% 31.67 US$301,895
2026-03-09 2026-03-05 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
17,295 -16.8%
31.67
US$547,705 		17,295 -16.8% 31.67 US$547,705
2026-03-09 2026-03-05 PlS Planned sale
Jover Placid

See "Remarks"

Officer
14,150 -67.6%
31.67
US$448,108 		14,150 -67.6% 31.67 US$448,108
2026-03-09 2026-03-05 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,127 -9.4%
31.67
US$35,690 		1,127 -9.4% 31.67 US$35,690
2026-03-09 2026-03-05 PlS Planned sale
Shields Matthew

EVP, Global Operations

Officer
17,295 -63.4%
31.67
US$547,705 		17,295 -63.4% 31.67 US$547,705
2026-03-05 2026-03-05 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2026-03-05 2026-03-05 PrS Proposed sale
Jover Placid

Officer; EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER

Officer
14,150
31.67
US$448,108 		14,150 31.67 US$448,108
2026-03-05 2026-03-05 PrS Proposed sale
Savage Brian

Officer; INTERIM CHIEF LEGAL OFFICER

Officer
1,127
31.67
US$35,690 		1,127 31.67 US$35,690
2026-03-05 2026-03-05 PrS Proposed sale
Fox Christine

Officer; EVP HEAD OF US COMMERCIAL

Officer
7,924
31.67
US$250,940 		7,924 31.67 US$250,940
2026-03-05 2026-03-05 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
20,025
31.67
US$634,160 		20,025 31.67 US$634,160
2026-03-05 2026-03-05 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
9,533
31.67
US$301,895 		9,533 31.67 US$301,895
2026-03-05 2026-03-05 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
37,372 -30.4%
32.95
US$1,231,310 		37,372 -30.4% 32.95 US$1,231,310
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
20,461 -14.2%
32.46
US$664,256 		20,461 -14.2% 32.46 US$664,256
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
33,512 -21.4%
32.46
US$1,087,950 		33,512 -21.4% 32.46 US$1,087,950
2026-03-06 2026-03-04 PlS Planned sale
Francis Richard D

President and CEO

Officer
23,393 -2.0%
32.46
US$759,442 		23,393 -2.0% 32.46 US$759,442
2026-03-06 2026-03-04 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
11,277 -10.4%
32.46
US$366,102 		11,277 -10.4% 32.46 US$366,102
2026-03-06 2026-03-04 PlS Planned sale
Fox Christine

EVP, U.S. Commercial

Officer
9,098 -10.8%
32.46
US$295,362 		9,098 -10.8% 32.46 US$295,362
2026-03-06 2026-03-04 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,186 -12.3%
32.46
US$38,503 		1,186 -12.3% 32.46 US$38,503
2026-03-06 2026-03-04 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,489 -19.4%
32.46
US$48,340 		1,489 -19.4% 32.46 US$48,340
2026-03-04 2026-03-04 PrS Proposed sale
Fox Christine

Officer; EVP HEAD OF US COMMERCIAL

Officer
9,908
32.46
US$321,658 		9,908 32.46 US$321,658
2026-03-04 2026-03-04 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
23,393
32.46
US$759,442 		23,393 32.46 US$759,442
2026-03-04 2026-03-04 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
11,277
32.46
US$366,102 		11,277 32.46 US$366,102
2026-03-04 2026-03-04 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
91,345
32.66
US$2,983,516 		91,345 32.66 US$2,983,516
2026-03-05 2026-03-03 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
66,735 -35.1%
32.36
US$2,159,538 		66,735 -35.1% 32.36 US$2,159,538
2026-03-05 2026-03-03 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
62,250 -56.3%
32.36
US$2,014,404 		62,250 -56.3% 32.36 US$2,014,404
2026-03-05 2026-03-03 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,274 -30.3%
32.36
US$41,227 		1,274 -30.3% 32.36 US$41,227
2026-03-05 2026-03-03 PlS Planned sale
Francis Richard D

President and CEO

Officer
412,032 -26.9%
32.36
US$13,333,314 		412,032 -26.9% 32.36 US$13,333,314
2026-03-05 2026-03-03 PlS Planned sale
Francis Richard D

President and CEO

Officer
30,903 -4.6%
32.36
US$1,000,018 		30,903 -4.6% 32.36 US$1,000,018
2026-03-05 2026-03-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
68,685 -44.5%
32.36
US$2,222,640 		68,685 -44.5% 32.36 US$2,222,640
Explore more

More insider trading research around Teva Pharmaceutical Industries Limited

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity